Mark Witmer

Author PubWeight™ 6.44^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route.	J Biol Chem	2009	1.49
2	Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).	J Med Chem	2007	0.91
3	A global benchmark study using affinity-based biosensors.	Anal Biochem	2008	0.91
4	An inhibitor binding pocket distinct from the catalytic active site on human beta-APP cleaving enzyme.	Biochemistry	2005	0.87
5	High-throughput high-content imaging assays for identification and characterization of selective AXL pathway inhibitors.	Assay Drug Dev Technol	2014	0.78
6	Novel inhibitors of IMPDH: a highly potent and selective quinolone-based series.	Bioorg Med Chem Lett	2003	0.77
7	Novel diamide-based inhibitors of IMPDH.	Bioorg Med Chem Lett	2002	0.77